Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 13/20 | 0.53 |
| ▸ | RARG | P13631 | 13/20 | 0.53 |
| ▸ | RARA | P10276 | 12/20 | 0.53 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 4/20 | 0.42 |
| ▸ | HNF4A | P41235 | 1/20 | 0.42 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.39 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.38 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7146567 | 1.00 | RARB (0.53) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL7137570 | 1.00 | RARB (0.53) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL7140836 | 0.86 | RARA (0.50) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL7140832 | 0.86 | RARA (0.50) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL7699618 | 0.85 | GRIK1 (0.42) | RARBRARGRARARAB9ANPC1 | |
| SCHEMBL7699617 | 0.85 | GRIK1 (0.42) | RARBRARGRARARAB9ANPC1 | |
| SCHEMBL10935850 | 0.83 | RARB (0.72) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL10935843 | 0.83 | RARB (0.72) | RARBRARGRARASTAT3RAB9A | |
| SCHEMBL7139314 | 0.83 | RARB (0.52) | RARBRARGRARARXRAHNF4A | |
| SCHEMBL7139553 | 0.75 | RARA (0.47) | RARBRARGRARASTAT3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180140637-A1 | EPIDERMAL NEURAL CREST STEM CELLS AS A SOURCE OF SCHWANN CELLS | SIEBER BLUM MAYA (US) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180140637-A1 | EPIDERMAL NEURAL CREST STEM CELLS AS A SOURCE OF SCHWANN CELLS | NES, NCSTN, SOX18 | RARB 190/4885RARG 215/4885RARA 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.